TARIS Biomedical scores $32 mln

By Iris Dorbian — 4 months ago

TARIS Biomedical, which focuses on developing new treatments for urologic diseases, has secured $32 million in funding. Flagship Ventures led the round with participation from Polaris Venture Partners and RA Capital Management. Also, TARIS has appointed Dr. Christopher Cutie as vice president of clinical development. And, the company has named Kevin Finney, most recently Allergan’s vice president and corporate development head, and Mark Iwicki, most recently president and CEO of Civitas Therapeutics, to its board of directors.

Continue

Selecta Biosciences raises $20 million

By Luisa Beltran — 1 year ago

Selecta Biosciences said Wednesday it has secured $20 million in equity funding from new and all of Selecta’s existing investors. Including the $20 million, Selecta said it has obtained a total of $78.6 Million in funding to date. Investors include Polaris Venture Partners, Flagship Ventures, OrbiMed Advisors, NanoDimension, Rusnano, I2BF, Eminent Venture Capital and Leukon Investments. Selecta is a clinical stage biotechnology company that is developing a class of targeted antigen-specific immune therapies.

Continue

VC-backed Genocea Biosciences hires new CFO

By Iris Dorbian — 2 years ago

Genocea Biosciences said Monday that it has named Jonathan Poole as chief financial officer. Previously, Poole worked at Shire where he served as senior vice president of finance for pipeline and technical operations. Based in Cambridge, Mass., Genocea Biosciences is a developer of T-cell vaccines. Genocea’s backers include Polaris Venture Partners, Lux Ventures, Skyline Ventures, Auriga Ventures, The Bill & Melinda Gates Foundation and Morningside Ventures.

Continue

Visterra closes Series A

By Angela Sormani — 2 years ago

Visterra, a developer of novel therapeutics to prevent and treat major infectious diseases, has secured $8.1 million in the final closing of its Series A financing round. This financing brings the total proceeds received to date from Series A to $34.2 million. Existing investors – Polaris Venture Partners, Flagship Ventures, Lux Capital, the Bill & Melinda Gates Foundation and Omega Funds – participated in the financing, as well as members of management and employees.

Continue

Apnex Medical Closes $10 Million Financing

By Angela Sormani — 3 years ago

Apnex Medical has secured financing totaling $10 million from New Enterprise Associates. The funds will be used to support the ongoing Apnex Clinical Study. Apnex develops medical devices aimed at helping people with sleep apnea. Other investors in the company include Domain Associates, Polaris Venture Partners and investor and Apnex chairman Michael Berman.

Continue

Boston Scientific to Acquire BridgePoint Medical

By Angela Sormani — 3 years ago

Boston Scientific Corporation is to acquire BridgePoint Medical. Minneapolis, Minnesota-based BridgePoint Medical was established in 2007 to develop and commercialize new technologies to treat challenging coronary artery disease. Investors include New Enterprise Associates, Polaris Venture Partners, Foundation Medical Partners and Michael Berman.

Continue

BalconyTV Attracts First Institutional Funding Round

By Angela Sormani — 4 years ago

Global online music video channel BalconyTV–Music With A View has secured its first institutional funding from Polaris Venture Partners, Lerer Ventures and Greycroft Partners. Former MTV Networks CEO Judy McGrath will also join the company in an advisory role. BalconyTV was founded by three Dublin friends who began filming daily performances of new and up-and-coming […]

Continue

Athletes’ Performance Scores $22.5m Backing from ABS Capital

By Angela Sormani — 4 years ago

Athletes’ Performance, a provider of performance training, nutrition and physical therapy for athletes, military and corporations, has secured a $22.5 million investment from ABS Capital Partners. ABS Capital joins the Company’s initial investor Polaris Venture Partners. PRESS RELEASE Athletes’ Performance, a leading provider of integrated performance training, nutrition and physical therapy for elite athletes, military […]

Continue

Polaris To Earn 10x Return On Ascend Health Acquisition

By Mark Boslet — 4 years ago

Polaris Venture Partners anticipates a 10x return on its investment in Ascend Health Corp., according to a news report. Ascend, an operator of nine psychiatric inpatient facilities, said Monday it had agreed to sell itself to Universal Health Services for $500 million. The deal will bring Polaris $115 million when the merger closes in the […]

Continue

Infinite Power Solutions Closes $10m Series D

By Angela Sormani — 4 years ago

US clean technology company Infinite Power Solutions has completed a $10 million Series D financing. Existing financial investors Generation Investment Management, D. E. Shaw Ventures, Polaris Venture Partners and Core Capital Partners co-led the financing, which also included participation by Applied Ventures, the venture capital arm of Applied Materials, In-Q-Tel and two additional strategic investors. […]

Continue

Adimab Closes “Oversubscribed” Series F Round

By Connie Loizos — 4 years ago

Adimab, a Lebanon, New Hampshire-based maker of an antibody discovery platform, has raised what it’s calling an “oversubscribed” Series F financing. Neither terms nor investors are being disclosed. The company has already raised roughly $25 million since its 2007 founding, including from Polaris Venture Partners, Borealis Ventures, and Google Ventures. PRESS RELEASE: Adimab, LLC, a leader […]

Continue

AMS Promotes former Atlas Venture COO to President

By Angela Sormani — 4 years ago

Accounting Management Solutions, a provider of outsourced accounting, financial management, and consulting services has promoted Don MacKenzie to company president. MacKenzie joined the company in 2010 as chief operating officer and will retain this title. Jim Bourdon, founder of the company, will remain chief executive officer. Prior to joining AMS in 2010, MacKenzie served as […]

Continue

Gift-Giving Wantful Secures Series A

By Angela Sormani — 4 years ago

San Francisco-based gift-giving service Wantful has secured a $5.5 million series A investment. Led by Polaris Venture Partners, the round also includes funding from previous investors including Harrison Metal, Greylock Partners and Forerunner Ventures, as well as angel investors. PRESS RELEASE — Wantful, a leading gift-giving service focused on helping you give exceptional gifts for […]

Continue

Promedior Raises $21.5 Million

By Angela Sormani — 4 years ago

Promedior, a clinical stage biotechnology company has raised $21.5M in a first closing of a Series D financing round. The financing was led by a new investor, Fibrotec Ventures with participation from all of Promedior’s existing venture investors, including Morgenthaler Ventures, HealthCare Ventures, Polaris Venture Partners, Forbion Capital Partners and Easton Capital Investment Group. This […]

Continue

Promedior Inks $21.5M

By Staff Report — 4 years ago

Malvern, Penn.-based Promedior Inc., a clinical stage biotechnology company developing therapeutics for fibroproliferative diseases, has held a $21.5 million first closing of its Series D round.  New investor Fibrotec Ventures led the round, which included existing shareholders Morgenthaler Ventures, HealthCare Ventures, Polaris Venture Partners, Forbion Capital Partners and Easton Capital Investment Group. This new round […]

Continue